Skip to content
10-K

Annual Report

MERRIMACK PHARMACEUTICALS INC

0000950170-24-027966

← back to feed
Filed
Mar 7, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 5, 2024 14.52M sh
Shares Diluted FY 2023 · Dec 31, 2023 14.3M sh
Shares Diluted FY 2023 · Dec 31, 2022 13.52M sh
Operating Cash Flow FY 2023 · Dec 31, 2023 −$1.52M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$1.74M
Short Term Investments FY 2023 · Dec 31, 2023 $12.89M
Short Term Investments FY 2023 · Dec 31, 2022 $0
Cash And Equivalents FY 2023 · Dec 31, 2023 $5.99M
Cash And Equivalents FY 2023 · Dec 31, 2022 $19.44M
Stockholders Equity FY 2023 · Dec 31, 2023 $18.75M
Stockholders Equity FY 2023 · Dec 31, 2022 $19.25M
Stockholders Equity FY 2023 · Dec 31, 2021 $14.19M
Current Liabilities FY 2023 · Dec 31, 2023 $441K
Current Liabilities FY 2023 · Dec 31, 2022 $589K
Total Liabilities FY 2023 · Dec 31, 2023 $441K
Total Liabilities FY 2023 · Dec 31, 2022 $589K
Current Assets FY 2023 · Dec 31, 2023 $19.18M
Current Assets FY 2023 · Dec 31, 2022 $19.83M
Total Assets FY 2023 · Dec 31, 2023 $19.19M
Total Assets FY 2023 · Dec 31, 2022 $19.84M
Eps Diluted FY 2023 · Dec 31, 2023 −$0.08
Eps Diluted FY 2023 · Dec 31, 2022 −$0.11
Eps Basic FY 2023 · Dec 31, 2023 −$0.08
Eps Basic FY 2023 · Dec 31, 2022 −$0.11
Operating Income FY 2023 · Dec 31, 2023 −$2.04M
Operating Income FY 2023 · Dec 31, 2022 −$1.73M